|
Sex, male/female
|
N = 26/8
|
|
Age, years (range)
|
67.3 ± 8.1 (50–84)
|
|
Height, cm
|
163.2 ± 7.9
|
|
Weight, kg
|
54.9 ± 7.6
|
|
Body mass index
|
20.6 ± 2.2
|
|
Smoking history
|
N = 31
|
|
Squamous cell carcinoma/adenocarcinoma
|
N = 33/1
|
|
Clinical stage, 0-I/II/III/IV
|
N = 12/4/16/2
|
|
Lymphadenectomy, 1/2/3 fields
|
N = 1/24/9
|
|
Preoperative adjuvant therapy
|
N = 22
|
|
COPD
|
N = 12
|
|
%VC
|
101.5 ± 14.1
|
|
%FEV1
|
94.0 ± 15.9
|
|
FEV1/FVC, %
|
73.0 ± 7.9
|
|
Open surgery/video-assisted thoracic surgery
|
N = 31/3
|
|
Operation time, min
|
520 ± 90
|
|
Blood loss during surgery, ml
|
719 ± 456
|
|
Intensive Care Unit stay, days
|
1.3 ± 0.6
|
|
Timing of extubation, 0/1/2 postoperative days
|
N = 23/9/2
|
|
Hospital stay after surgery, days
|
21.2 ± 15.0
|
|
Walking with support, postoperative days
|
1.9 ± 1.8
|
